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Summary
Breast cancer is one of the most prevalent cancers in the world amongst women. Incidence of breast cancer in Croatia, 
in 2012 was 2227. The crude incidence rat for Croatia was 100,4 (on 100 000 persons) and standardized incidence rate for the 
world population was 53,7 (1,2).
As a consequence of advancements in available diagnostic procedures and treatments, the rate of survival is increas-
ing, hence it is expected that the population susceptible to pain as a complication would also increase (3). The persistent pain 
causes a negative physical and psyhosocial impact on patient’s life (3,4). Early identifi cation and accurate assessment of pain 
after breast cancer surgery includes: physicians and nurses in the ICU, surgical and oncological departments, general prac-
titioners, psychiatrists, neurologists, palliative care teams and family members (5). In this review we presented results of 
early and regular assessment of pain intensity and detection of factors involved in the emergence and spread of pain that 
occurs after breast cancer surgery (6,7).
Herein, a modifi ed questionnaire about pain is described as used in our clinical practice, based on which a combina-
tion of analgesic therapy is applied and a more satisfactory response in patients treated for breast cancer is obtained.
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VAŽNOST PRAVOVREMENE I REDOVITE PROCJENE BOLI NAKON OPERACIJE RAKA DOJKE
Sažetak
Rak dojke je jedan od najčešćih oblika raka u svijetu među ženama. Incidencija raka dojke u Hrvatskoj, u 2012. godini, 
je 2227 slučaja. Stopa učestalosti za Hrvatsku iznosila je 100,4 (na 100 000 osoba), a standardizirana učestalost za svjetsku 
populaciju je 53,7 (1,2).
Kao posljedica napretka u dostupnoj dijagnostici i liječenju, stopa preživljavanja oboljelih je u porastu te se očekuje 
porast broja stanovništva s komplikacijama boli (3). Stalna bol ima negativne fi zičke i psihosocijalne učinke na život obo-
ljelih (3,4). Rano prepoznavanje i točna procjena boli, nakon operacije raka dojke, uključuje: liječnike i medicinske sestre u 
intenzivnim jedinicama, kirurškim i onkološkim odjelima; liječnika obiteljske medicine, psihijatra, neurologa, tim palijativ-
ne skrbi i članove obitelji (5).
U ovom preglednom članku želimo prikazati važnost rane i redovite procjene kvalitete i jačine boli kao i otkrivanje 
čimbenika odgovornih za nastanak i širenje boli koja nastaje nakon operacije raka dojke (6,7). Također smo prikazali primjer 
modifi ciranog upitnika o boli koji smo koristili u našoj kliničkoj praksi, prema kojemu smo primjenili kombinaciju analget-
ske terapije i dobili zadovoljavajući odgovor u bolesnica operiranih od karcinoma dojke.
KLJUČNE RIJEČI: rak dojke, operacija raka dojke, upitnik za bol, klinička praksa, procjena boli
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INTRODUCTION
Persistent pain and sensory disturbances fol-
lowing surgical treatment for breast cancer is a 
signifi cant clinical problem. The pathogenic me-
chanisms are complex and may be related to 
patient characteristics, surgical technique, and 
adjuvant therapy (8,9).
In the breast cancer, the pathogenic mecha-
nisms are multiple, including nerve damage re-
lated to surgical technique resulting in risk of in-
tercostobrachial neuralgia, neuroma pain or phan-
tom breast pain (8). Diff erent types of sensory 
disturbances (eg. allodynia, hyperpathia, after 
sensations, burning or sensory loss) are sequelae 
of other surgical procedures and may be an 
important part of the pain characteristics in breast 
cancer (9). Postsurgery pain is a common problem 
and often unnoticed in health care. If we do not 
notice it on time and treat correctly, it can pre-
dispose to creating persistant pain through 
multiple mechanisms and it may sensitive the 
pain system facilitating the development of 
chronic pain after new injury.
FACTORS ASSOCIATED 
WITH PAIN INTENSITY
Age and treatment modalities: The most im-
portant determinant of persistent pain and sensory 
disturbances was younger age (<40 years), al-
though age was not related to the severity of the 
pain reported. The observed association between 
chronic pain and chemotherapy could be due to 
age, because younger women more often receive 
chemotherapy. The radiotherapy was an inde-
pendent and signifi cant risk factor for reporting 
pain, but the extent of the radiation fi eld did not 
infl uence to it. In the future, localized intraoperative 
radiotherapy may be a way to reduce persistent 
pain related with radiotherapy due to bett er 
defi ning anatomic application (2,7,9).
Size of surgical area: Pain was reported most 
frequently in the area of the breast. The frequency 
appeared independent of type of breast surgery, 
although women who underwent mastectomy 
reported slightly but signifi cantly more severe 
pain than women undergoing breast conserving 
surgery (BCS). Chronic pain after breast cancer 
surgery and adjuvant therapy may predominantly 
be characterized as a neuropathic pain state and 
probably related to intraoperative injury of the 
intercostal-brachial nerve (15–17). Persistent pain 
in the surgical area after breast cancer surgical 
treatment is a clinically signifi cant problem in 
approximately 25% to 50% of patients. Although 
BCS and sentinel node dissection have reduced 
complaints, future strategies for further impro-
vement should include nerve-sparing axillary 
dissection and att ention to patients with other 
chronic pain symptoms (10,12).
Psychophysical status, preoperative breast 
pain and acute postoperative pain intensity are 
well-known risk factors related with a persistent 
postsurgical pain (9,11,12,15,19). Also postsurgical 
pain state may be related with existence of other 
pain syndromes (headache, low back pain), which 
may suggest that a preoperative general pain 
hypersensitivity due to psychosocial or genetic 
factors may be important pathogenic mechanisms 
and therefore have to be included in preventive 
and therapeutic trials in the future.
OBJECTIVES AND METHODS
To examine prevalence of breast cancer pain 
and factors associated with persistent pain after 
surgical treatment we searched ScienceDirect, 
PubMed, PubMed Health, ScienceDirect and 
MEDLINE. Available articles and data include an 
estimate of severity of pain and the factors that are 
responsible for its emergence, expansion and 
maintenance (9,10,12,17).
However, almost all information is retros-
pective based on questionnaires, often from single 
centers or small cohorts, not allowing suffi  cient 
analyses of the many risk factors. In addition, 
surgical principles of treatment have changed in 
recent years, including more breast-conserving 
surgery (BCS) and use of the sentinel node 
technique, and principles for radiotherapy and 
chemotherapy have been adjusted to more recent 
scientifi c data, thereby limiting interpretation of 
previous studies except for an agreement on 
persistent pain being a signifi cant clinical problem 
(13,15-18).
The most frequently used Questionnaires:
(i) Modifi ed Post-operative Pain Questionnaire.
A modifi ed version of the Post-operative 
Pain Questionnaire (the original of which was 
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used to examine long-term postt horacotomy pain) 
was used to assess postsurgical pain in the region 
of the axilla. This 12-item instrument solicits 
information about the presence and absence of 
postoperative pain and discomfort, its intensity, 
and its functional signifi cance throughout the 
post-ALND time period.
(ii) Pain Disability Index.
The Pain Disability Index (PDI) was used to 
determine the extent to which ALND-related pain 
and discomfort interferes with the following seven 
life areas: family/home responsibility, recreation, 
social activity, self-care, life-support activity, 
sexual activity, and occupation (28).
(iii) Short-form McGill Pain Questionnaire:
Like the McGill Pain Questionnaire, the 
Short-form McGill Pain Questionnaire (SF-MPQ) 
measures quantitative and qualitative experiences 
of pain. It is composed of sensory and aff ective 
pain scales, a Present Pain Intensity (PPI) scale, 
and a visual analog pain scale. The SF-MPQ 
correlates very highly with the pain indices of the 
long form in patient populations, including cancer 
patients (30).
(iv) Quality of Life Questionnaire.
The European Organization for Research and 
Treatment of Cancer Quality of Life Questionnaire 
is an internationally recognized instrument for the 
assessment of quality of life in cancer patients. The 
instrument is composed of fi ve functional scales 
(physical, role, cognitive, emotional, and social), 
three symptom scales (fatigue, pain, and nausea 
and vomiting), a global quality of life scale, and 
six single items that measure dyspnea, sleep 
disturbance, appetite loss, constipation, diarrhea, 
and fi nancial impact. Psychometric validation of 
this questionnaire has previously been reported, 
and the instrument has been used to identify 
meaningful changes in quality of life over time. 
The global quality of life scale correlates sig-
nifi cantly and substantially with all the functional 
and symptom scales. For the present sample, the 
correlations between the global quality of life scale 
and the functional and symptom scales were all 
statistically signifi cant (P< .001 ) (29).
(v) Mental Health Inventory
The Mental Health Inventory measures symp-
toms of psychological distress and well-being 
along the following fi ve dimensions: anxiety, 
depression, loss of behavioral/emotional con-
trol, positive eff ect, and interpersonal ties. Relia-
bility of the Mental Health Inventory is very high 
(r = .96) (5).
The questionnaire, which we use at our 
institution is simplifi ed version of McGill’s 
questionnaire about pain. It is slightly modifi ed 
according to the needs and requests of the 
treatment that is carried out in our Clinic. 
Questions and pictures in our questionnaire are 
easy to use. This is understandable for most 
patients and giving a realistic assessment of the 
qualitative and quantitative components of pain 
at any time during treatment. This form of the 
questionnaire would be suitable for nurses and 
doctors in surgical, oncology departments, ane-
sthesiologists in clinic for pain and other members 
involved in the treatment and care of the patient 
with cancer (family doctors, psychologists, mem-
bers of the palliative care and family).
In this questionnaire the area of the breast is 
defi ned as the operated breast area or the area 
from which the breast was removed.
To determine the prevalence of symptoms 
for each major topic, dichotomous yes or no 
questions were used. Regarding pain and sensory 
disturbances, the women were asked systema-
tically to address 4 specifi c regions of symptoms:
1. area of the breast (defi ned as either the 
aff ected breast or the area from which the breast 
was removed), 2. axilla, 3. arm, and 4. side of the 
body, rating pain severity and frequency in each 
region.
To estimate severity of pain, a numeric rating 
scale from 0 to 10 scores was used in which 0 
indicated no pain and 10 indicated worst 
imaginable pain (13,14). For the reporting of 
results regarding severity of pain, scores of 1 to 
3 were categorized as light pain, scores of 4 to 6 
as moderate pain, and scores of 7 to 10 as severe 
pain. Worst pain was defi ned as the highest pain 
score of the 4 regional pain scores.
The frequency of symptoms was assessed by 
a 3-point verbal categorical scale: 1. every day or 
almost every day, 2. 1 to 3 days a week, or 3. more 
rarely. Questions were asked about physician 
visits due to: pain in the operated region, use of 
analgesics, other treatment for pain in the aff ected 
region, or pain in other locations (e.g., low back 
pain, headache).
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The study included 121 patients who un-
derwent mastectomy with axillary lymph node 
dissection due to a cancer. All patients fi lled out 
questionnaire about the pain that has been mo-
difi ed according to our criteria and the analgesic 
treatment (Figure 1) during preoperative exa-
mination. For the treatment of postoperative pain 
on the day of the surgery all women have received 
NSAR drugs i.v. (diclofenak) about fi fteen minutes 
before the end, and twelve hours after the com-
pletion of surgery. Eight hours after the procedure 
they received opioid analgetics i.v. (tramadol). 
Second postoperative day therapy was continued 
orally. We monitored pain intensity at rest and in 
motion for 48 hours postoperatively in all patients. 
The intensity of pain was measured using the 
visual analogue numerical (VAS) scale. The 
additional requested or complementary analgesic 
therapy that was applied to the surgical wards 
was also recorded. With protocol for analgesia 
which we use at our institution and application of 
pre-emptive analgesia and analgesia on demand, 
according to the results obtained from the 
modifi ed questionnaire about pain, we achieved 
satisfactory control of early postoperative pain in 
majority of patients. Only 11 of the 121 patients 
asked for additional analgesic therapy. There were 
no statistically signifi cant diff erence with regards 
to age.
DISCUSSION
Pain is a multifactorial experience, not just a 
sensation. Emotion, perception and past expe-
rience all aff ect an individual’s response to noxious 
stimuli. Improved postoperative pain control 
through innovation and creativity may improve 
compliance, ease of delivery, reduce length of 
hospital stay and improve patient satisfaction. 
Patient education, early diagnosis of symptoms 
and aggressive treatment of pain using an 
integrative approach, combining pharmacotherapy 
as well as complementary technique seem to be a 
good strategy to control the pain at diff erent 
disease stages (3,4,11,12).
Of the many questionnaires which were used 
in assessing intensity and quality of pain, only a 
few, have been used for a long time and were 
widely accepted (28,29,30).
Our intention was to create a simple ques-
tionnaire to assess pain in women treated for 
breast cancer which would include qualitative 
and quantitative indicators of pain and its origin. 
The questionnaire was designed to detect the 
occurrence of acute pain early and predict its 
progression, as well as to detect signs of de-
terioration of chronic pain (acute exacerbation). 
The questionnaire should be accessible and 
available to everyone involved in the treatment of 
cancer patient, adapted to intellectual and cultural 
diff erences (6,7,10,14). In our case the population 
is rather homogenou s and no diffi  culties with 
interpretation were recognised.
The compliance and good overall pain control 
we detected in preliminary results of our study 
stressed another point: improved communication 
with patients, members of the palliative team and 
the family, ensured regular monitoring of the 
course of treatment which might be the reason for 
improved pain control.
CONCLUSION
Our intention was to assess the eff ect of 
prescribed analgesic therapy based on the modi-
fi ed pain questionnaire in the postoperative 
period, and identify early indicators of dete-
rioration in underlying disease or complications 
operational or other medical treatment. When 
creating the modifi ed questionnaire we included 
factors aff ecting pain modalities in early post-
operative period, in order to prevent amplifi cation 
of pain and the occurrence of pathological pain 
(21,23,24,26). We also achieved greater satisfaction 
and involvement of patients in the course of future 
treatment.
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